Carvedilol and Status epilepticus - a phase IV clinical study of FDA data
Summary:
Status epilepticus is reported as a side effect among people who take Carvedilol (carvedilol), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Janumet, and have Diabetes.
The phase IV clinical study analyzes which people have Status epilepticus when taking Carvedilol. It is created by eHealthMe based on reports of 110,224 people who have side effects when taking Carvedilol from the FDA, and is updated regularly.
What is Carvedilol?
Carvedilol has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 112,649 Carvedilol users. Check the latest studies of Carvedilol.
What is Status epilepticus?
Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure) is found to be associated with 672 drugs and 948 conditions by eHealthMe. Check the latest studies of Status epilepticus.
110,224 people reported to have side effects when taking Carvedilol.
Among them, 60 people (0.05%) have Status epilepticus.

Among these 60 people:
How long have people been on Carvedilol when they have Status epilepticus? *
- < 1 month: 50 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 50 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Status epilepticus when taking Carvedilol? *
- female: 15.25 %
- male: 84.75 %
What is the age of people who have Status epilepticus when taking Carvedilol? *
- 0-1: 1.79 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 8.93 %
- 30-39: 0.0 %
- 40-49: 3.57 %
- 50-59: 12.5 %
- 60+: 73.21 %
What are other drugs people take besides Carvedilol? *
- Janumet: 26 people, 43.33%
- Avastin: 25 people, 41.67%
- Eliquis: 25 people, 41.67%
- Amlodipine: 21 people, 35.00%
- Levetiracetam: 14 people, 23.33%
- Spironolactone: 14 people, 23.33%
- Allopurinol: 14 people, 23.33%
- Torsemide: 14 people, 23.33%
- Simvastatin: 13 people, 21.67%
- Ramipril: 13 people, 21.67%
What are other side effects people have besides Status epilepticus? *
- Seizures (abnormal excessive or synchronous neuronal activity in the brain): 31 people, 51.67%
- Eye Movement Disorder: 27 people, 45.00%
- Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 26 people, 43.33%
- Muscle Spasms (muscle contraction): 25 people, 41.67%
- Oculogyric Crisis (a spasmodic movement of the eyeballs into a fixed position due to medicine reaction): 25 people, 41.67%
- Hypotension (abnormally low blood pressure): 8 people, 13.33%
- Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 8 people, 13.33%
- Confusional State: 7 people, 11.67%
- Cardiac Arrest: 6 people, 10.00%
- Head Injury: 6 people, 10.00%
What are the existing conditions these people have? *
- Diabetes: 27 people, 45.00%
- Cardiac Disorder: 26 people, 43.33%
- Renal Disorder (kidney disease): 26 people, 43.33%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 26 people, 43.33%
- Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 26 people, 43.33%
- Gout (uric acid crystals building up in the body): 26 people, 43.33%
- Heart Disease: 26 people, 43.33%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 25 people, 41.67%
- Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 21 people, 35.00%
- High Blood Cholesterol: 20 people, 33.33%
* Approximation only. Some reports may have incomplete information.
Do you take Carvedilol and have Status epilepticus?
- Check whether Status epilepticus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Carvedilol:
- Carvedilol (112,649 reports)
Status epilepticus treatments and more:
- Status epilepticus (19,280 reports)
How severe was Status epilepticus and when was it recovered:
Expand to all the drugs that have ingredients of carvedilol:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Carvedilol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Status epilepticus:
- Status epilepticus (672 drugs)
Browse all the conditions that are associated with Status epilepticus:
- Status epilepticus (948 conditions)
Related publications that referenced our studies
- Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
- Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
- Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
- Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on carvedilol (the active ingredients of Carvedilol) and Carvedilol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Aranesp cause Skin Irritation? - 2 seconds ago
- Could Paracetamol cause Tongue Discoloration? - 3 seconds ago
- Theo-Dur vs. Xolair, side effect and effectiveness comparison - 6 seconds ago
- Could Voriconazole cause Haematuria Aggravated? - 13 seconds ago
- Could Flumazenil cause Thrombocytopenia? - 14 seconds ago
- Drug interactions of Westcort and Singulair - 16 seconds ago
- Could Etodolac cause Enlarged Heart? - 23 seconds ago
- Could Micardis cause Arteriosclerosis Of The Extremities? - 25 seconds ago
- Drug interactions of Zyrtec and Ubrelvy - 33 seconds ago
- Could Fish Oil cause Drug Level Below Therapeutic? - 38 seconds ago